Demographics (2)
- AGE - Subject age at biopsy (phv00534900.v1.p1)
- SEX - Biological sex (phv00534896.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00534901.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00534907.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00534895.v1.p1)
- DAYS_CULTURE - Days in culture (phv00534910.v1.p1)
- DISEASE - Lymphoma histology (phv00534902.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00534909.v1.p1)
- IS_TUMOR - Tumor status (phv00534908.v1.p1)
- SAMPLE_ID - Sample ID (phv00534906.v1.p1)
- SAMPLE_ID - Sample ID (phv00534898.v1.p1)
- STAGE - Lymphoma stage (phv00534903.v1.p1)
- SUBJECT_ID - Subject ID (phv00534899.v1.p1)
- SUBJECT_ID - Subject ID (phv00534894.v1.p1)
- SUBJECT_ID - Subject ID (phv00534897.v1.p1)
- TIMING - Timing of biopsy (phv00534904.v1.p1)
- TREATMENT - Organoid immunotherapy treatment (phv00534911.v1.p1)
- UNTREATED - Prior lymphoma therapy (phv00534905.v1.p1)